{
    "clinical_study": {
        "@rank": "146191", 
        "arm_group": [
            {
                "arm_group_label": "Diphenhydramine", 
                "arm_group_type": "Active Comparator", 
                "description": "Increments of 25 mcg to maximum of 3 times (total 75 mcg)"
            }, 
            {
                "arm_group_label": "Midazolam", 
                "arm_group_type": "Active Comparator", 
                "description": "1.5 mg increments up to 3 times (maximum 4.5 mg)"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients who are undergoing colonoscopy and are not adequately sedated after initial\n      standard sedation with midazolam 5 mg and fentanyl 100 mcg will be randomly assigned to\n      receive diphenhydramine vs. continued midazolam, and their level of sedation will be\n      assessed.  Our hypothesis is that diphenhydramine will provide better sedation than\n      continued administration of midazolam during colonoscopy in patients not achieving adequate\n      sedation with standard doses of midazolam plus fentanyl."
        }, 
        "brief_title": "Randomized Trial of Diphenhydramine Versus Continued Midazolam in \"Difficult-to-sedate\" Patients Undergoing Colonoscopy", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sedation", 
            "Endoscopy"
        ], 
        "detailed_description": {
            "textblock": "Patients who are undergoing colonoscopy and are not adequately sedated after initial\n      standard sedation with midazolam 5 mg and fentanyl 100 mcg will be randomly assigned to\n      receive diphenhydramine (up to 3 incremental doses of 25 mcg each) vs. continued midazolam\n      (up to 3 incremental doses of 1.5 mg each).  the level of sedation will be assessed using\n      the MOAA/S scale 2-3 minutes after each administration to determine if they are sufficiently\n      sedated to begin colonoscopy.  The patient, the healthcare team involved in performing the\n      endoscopy, and the investigator assessing sedation will be blinded to the therapy.  Our\n      hypothesis is that diphenhydramine will provide better sedation than continued\n      administration of midazolam during colonoscopy in patients not achieving adequate sedation\n      with standard doses of midazolam plus fentanyl."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients >18 years-old who are undergoing elective colonoscopy with conscious\n             sedation\n\n        Exclusion Criteria:\n\n          -  allergy or prior adverse reactions to diphenhydramine\n\n          -  medical contraindications to use of diphenhydramine (e.g. closed angle glaucoma)\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01769586", 
            "org_study_id": "0003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Diphenhydramine", 
                "intervention_name": "Diphenhydramine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Midazolam", 
                "intervention_name": "Midazolam", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Diphenhydramine", 
                "Promethazine", 
                "Midazolam"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sedation", 
            "Endoscopy", 
            "Diphenhydramine", 
            "Midazolam"
        ], 
        "lastchanged_date": "January 14, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "West Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06516"
                }, 
                "name": "VA Connecticut Healthcare System"
            }, 
            "investigator": {
                "last_name": "Loren Laine, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Trial of Diphenhydramine Versus Continued Midazolam in \"Difficult-to-sedate\" Patients Undergoing Colonoscopy", 
        "overall_contact": {
            "email": "loren.laine@yale.edu", 
            "last_name": "Loren Laine, MD", 
            "phone": "203-937-3462"
        }, 
        "overall_official": {
            "affiliation": "VA Connecticut Healthcare System", 
            "last_name": "Loren Laine, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of patients who achieve adequate sedation to allow colonoscopy (defined as MOAA/S \u22643)", 
            "safety_issue": "No", 
            "time_frame": "Approximately 10 minutes or less"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01769586"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "VA Connecticut Healthcare System", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "VA Connecticut Healthcare System", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}